Katherine Eade
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Katherine Eade
Katherine Eade is recorded as Chairman at Harvard Bioscience Inc (HBIO). Harvard Bioscience Inc reported in an 8-K filed June 2, 2025 that Katherine Eade was appointed Lead Independent Director, effective June 2, 2025.
“One June 2, 2025, the Board appointed Katherine Eade as the Board’s Lead Independent Director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Harvard Bioscience Inc (HBIO)
SEC 8-K
Current2025-06-02–present
-
Current
2025-06-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harvard Bioscience Inc
Other people whose current roles at this company are on record from its filings.
- Former Chairman CEO
- John Duke CEO, Board Member
- Mark Frost CFO
- Kenneth Olson COO
- Bertrand Loy Board Member
- Bill Snider Board Member
- John D. Duke Board Member
- Katherine A. Eade Board Member
- Mr. William A. Snider Board Member
- Rob Gagnon Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.